New extension enables researchers to explore the REAL Space of 11 billion readily accessible compounds directly from StarDrop CAMBRIDGE, UK, KIEV, UKRAINE and SANKT AUGUSTIN, GERMANY – Optibrium™, BioSolveIT™ and Enamine™, leading providers of software and services for drug discovery, today announce a three-way collaboration enabling efficient search of Enamine’s REAL Space directly from within Optibrium’s […]

Collaboration between drug companies and contract research partners drives innovation in evolving business environment. Columbus, Ohio – CAS, a division of the American Chemical Society, announced today that leading contract research, development and manufacturing organization (CRO/CDMO) BioDuro has signed a five-year agreement for SciFindern. This agreement provides enterprise-wide access to the most advanced scientific information solution […]

RESEARCH TRIANGLE PARK, N.C. — RTI International, a leading research institute, today announced a follow-on investment in PierianDx to help empower leading health institutions and diagnostic laboratories to build world-class precision medicine programs. The transaction includes RTI’s participation in a $27 million Series B funding round, which includes new investors ATW Partners and SJF Ventures along with […]

Cross-industry collaboration will accelerate digital solutions and support R&D innovation by customers CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, has become a member of the Pistoia Alliance, a global, not-for-profit alliance of life science companies, vendors, publishers and academic groups working to lower barriers to innovation in life science and healthcare […]

Leading immuno-oncology company adopts Genedata Biologics to support the discovery and development of TCRs for adoptive cell therapies and bispecific TCR molecules Basel, Switzerland Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Immatics Biotechnologies, a clinical-stage biopharmaceutical company developing T-cell receptor (TCR)-based cancer immunotherapies, has adopted Genedata Biologics® to streamline their R&D […]

First-in-class software platform digitalizes Twist Biopharma’s innovative antibody lead identification and optimization SAN FRANCISCO–Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Twist Biopharma, a division of Twist Bioscience (NASDAQ: TWST), has adopted Genedata Biologics® to support their R&D innovation for biologics drug discovery services. In addition, Twist will use the […]

Genedata Selector® deployed to streamline complex cell line development processes Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced an expansion of its collaboration with Boehringer Ingelheim, a research-driven pharmaceutical company, to digitalize and automate complex cell line development processes. As part of this collaboration, Genedata Selector has been deployed […]

Lyon, France — Hitachi, Ltd. (TSE:6501, “Hitachi”) and Centre Léon Bérard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon […]

BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, today announced that has established a Singapore-based entity in order to spearhead its activities in the Asia Pacific region, including China. To mark the occasion, BC Platforms is jointly hosting a launch event with the Finnish Government (Business Finland) and IQVIA […]

Mastermind Genomic Search Engine Now Filters Evidence by Phenotype – Critical for the Genetic Interpretation of Rare Diseases Genomenon® announced the release of Mastermind® version 2.0. The Genomic Search Engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare […]